Arca Biopharma (ABIO)

Arca Biopharma (ABIO) Financial Statements


Arca Biopharma Financial Overview

Arca Biopharma's market cap is currently ―. The company's EPS TTM is $-0.555; its P/E ratio is -3.75; Arca Biopharma is scheduled to report earnings on August 2, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -1.80M$ -1.55M$ -2.55M$ -3.22M$ -3.28M
EBITDA$ -1.80M-$ -2.52M$ -3.19M$ -3.25M
Net Income Common Stockholders$ -1.35M$ -1.17M$ -2.33M$ -3.15M$ -3.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.85M$ 42.45M$ 43.94M$ 46.44M$ 49.06M
Total Assets$ 42.04M$ 43.09M$ 44.97M$ 48.10M$ 51.01M
Total Debt$ 262.00K$ 280.00K$ 301.00K$ 329.00K$ 357.00K
Net Debt$ -40.59M$ -42.16M$ -43.64M$ -46.11M$ -48.70M
Total Liabilities$ 1.53M$ 43.09M$ 2.24M$ 3.14M$ 3.08M
Stockholders Equity$ 40.53M$ 41.67M$ 42.73M$ 44.96M$ 47.94M
Cash Flow-
Free Cash Flow$ -1.59M$ -1.49M$ -2.50M$ -2.62M$ -4.30M
Operating Cash Flow$ -1.59M$ -1.49M$ -2.50M$ -2.62M$ -4.30M
Investing Cash Flow--$ 0.00$ 0.00$ -2.00K
Financing Cash Flow--$ 0.00$ 0.00$ 0.00
Currency in USD

Arca Biopharma Earnings and Revenue History

Arca Biopharma Debt to Assets

Arca Biopharma Cash Flow

Arca Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis